Mannkind Stock Market Invest

Companies
MannKind to Showcase Innovations at the 2024 Cantor Fitzgerald Global Healthcare Conference Sep 11, 2024
Companies
INHALE-3 Study Shows Positive Results for Inhaled Insulin in T1D Patients, Implications for MannKind Corporation Jun 23, 2024
Pharmaceuticals
MannKind Gains FDA Approval to Commence Phase 3 Trials for NTM Treatment Apr 30, 2024